| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/03/2003 | WO2003053221A2 Methods using proton pump inhibitors |
| 07/03/2003 | WO2003053219A2 Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 07/03/2003 | WO2003053169A1 Soft drink replacer |
| 07/03/2003 | WO2003053167A1 Composition for promotion of bone growth and maintenance of bone health |
| 07/03/2003 | WO2003053165A1 Matrix-forming composition containing pectin |
| 07/03/2003 | WO2003053146A1 Composition and method for improving sexual desire and overall sexual vitality |
| 07/03/2003 | WO2003053142A2 Highly crosslinked biocidal polystyrene hydantoin particles |
| 07/03/2003 | WO2003030823A3 Combinations for the treatment of immunoinflammatory disorders |
| 07/03/2003 | WO2003026697A3 Organoleptically acceptable intraorally disintegrating compositions |
| 07/03/2003 | WO2003026643A3 Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors |
| 07/03/2003 | WO2003026611A3 Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal |
| 07/03/2003 | WO2003018788A3 Improved nitroreductase enzymes |
| 07/03/2003 | WO2003017942A3 Ascorbic acid derivatives with amino acids |
| 07/03/2003 | WO2003017931A3 Simmondsin processing methods and products |
| 07/03/2003 | WO2003016499A3 Combinatorial methods for inducing cancer cell death |
| 07/03/2003 | WO2003013476B1 Compositions and methods to prevent abuse of opioids |
| 07/03/2003 | WO2003013440A3 Treatment and prevention of heat shock protein-associated diseases and conditions |
| 07/03/2003 | WO2003010284A3 Antisense modulation of c-reactive protein expression |
| 07/03/2003 | WO2002098898A3 FLJs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 07/03/2003 | WO2002094861A3 Genes and proteins involved in the biosynthesis of enediyne ring structures |
| 07/03/2003 | WO2002094849A3 Process for the production of 6, 7 - dihydroxy steroid compounds by allylic oxidation of steroid - 5 - ene compounds to steroid - 5 - ene - 7 - one compounds followed by hydroboration and oxidation and intermediates of this process |
| 07/03/2003 | WO2002085338B1 Ipratropium formulation for pulmonary inhalation |
| 07/03/2003 | WO2002076497A3 Method and composition |
| 07/03/2003 | WO2002072616A3 Transfection complexes |
| 07/03/2003 | WO2002062295A3 Pyridine-substituted benzanilides as potassium ion channel openers |
| 07/03/2003 | WO2002059604A3 Diagnosis and treatment of multiple sclerosis |
| 07/03/2003 | WO2002058734A3 Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions |
| 07/03/2003 | WO2002058732A3 Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 07/03/2003 | WO2002024754A8 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative |
| 07/03/2003 | WO2002018389A3 Thienopyrimidine |
| 07/03/2003 | WO2002016340A8 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 07/03/2003 | WO2000074667A3 Compositions active in telomere damage comprising a taxane and telomerase inhibitor |
| 07/03/2003 | US20030125800 Drug-delivery endovascular stent and method for treating restenosis |
| 07/03/2003 | US20030125714 Comprises inner compartments enclosed within semipermeable membrane coated with drugs; osmosis |
| 07/03/2003 | US20030125659 Dosage of transdermal delivery systems |
| 07/03/2003 | US20030125654 Bandage, methods of producing and using same |
| 07/03/2003 | US20030125572 Useful as a cosmetic constituent, antioxidant, radical scavenger or anti-inflammatory agent |
| 07/03/2003 | US20030125569 Use of packing strip as a holographic data carrier |
| 07/03/2003 | US20030125568 Defects in the crystal lattice are detectable by X-ray analysis, e.g. by smaller line spacings with otherwise predominantly identical lines or bands; antiepileptic agent |
| 07/03/2003 | US20030125565 2,5-dioxoimidazolidine or 2-thio-5-oxoimidazolidine derivatives suitable for the therapy and prophylaxis of inflammatory disorders, for example of rheumatoid arthritis, or of allergic disorder |
| 07/03/2003 | US20030125559 Methods for synthesizing ether compounds and intermediates therefor |
| 07/03/2003 | US20030125557 1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/03/2003 | US20030125533 Regulation of human sphingosine kinase-like protein |
| 07/03/2003 | US20030125532 Kneading then irradiating paste to form elastic gel; microbiocides |
| 07/03/2003 | US20030125531 Arylation method for the functionalization of O-allyl erythromycin derivatives |
| 07/03/2003 | US20030125509 Indomethacin entrapped within polysaccaride (dextran) or proteins |
| 07/03/2003 | US20030125391 Pharmaceutical solutions of modafinil compounds |
| 07/03/2003 | US20030125390 Method of treatment and prophylaxis |
| 07/03/2003 | US20030125388 5-Aminolevulinic acid formulation dissolved/dispersed in non-aqueous solvents |
| 07/03/2003 | US20030125387 Antioestrogens, capable of eliciting complete ablation of the trophic effects of oestrogens; cancer therapy |
| 07/03/2003 | US20030125386 Fatty acid nutritional supplement |
| 07/03/2003 | US20030125385 Prepared by mixing gamma-hydroxybutyrate and a pH-adjusting agent in an aqueous medium |
| 07/03/2003 | US20030125384 Administering agent that selectively inhibits bacterial DNA replication initiation; for disease or disorder caused by or associated with E. coli or H. pylori infection |
| 07/03/2003 | US20030125383 For treating or preventing emphysema, cancer and dermatological disorders |
| 07/03/2003 | US20030125382 Alprostadil alkyl ester-containing composition for external application |
| 07/03/2003 | US20030125381 With halogenated furanones and related 3-haloalkenones |
| 07/03/2003 | US20030125380 Tricyclic rantes receptor ligands |
| 07/03/2003 | US20030125379 Pharmaceutical compositions |
| 07/03/2003 | US20030125378 Skin treatment, cosmetics |
| 07/03/2003 | US20030125377 Aromatase inhibitors from Broussonetia papyrifera |
| 07/03/2003 | US20030125376 Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| 07/03/2003 | US20030125375 Eurotinones, and derivatives thereof, processes for preparing them, and their use |
| 07/03/2003 | US20030125374 Enhancement of taxane-based chemotherapy by a CDK1 antagonist |
| 07/03/2003 | US20030125373 Or conditions characterized by abnormal angiogenesis or to treat non-tumorigenic angiogenesis-dependent diseases that are characterized by abnormal growth of blood vessels |
| 07/03/2003 | US20030125372 In which resistance results from conversion of an amide bond to an ester bond in cell wall peptide precursors of bacteria which comprises using an antibacterial amount of vancomycin and an agent effective to selectively cleave ester bond |
| 07/03/2003 | US20030125371 Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| 07/03/2003 | US20030125369 New indenoindolone compounds |
| 07/03/2003 | US20030125368 (1,2,4) triazol-1-yl)-benzenesulfonyl derivatives useful to treat osteoarthritis, rheumatoid arthritis, colon cancer and Alzheimer's disease, in mammals; cyclooxygenase (COX)-2 inhibitor |
| 07/03/2003 | US20030125367 Administering a patient with bacterial infections a oxazolidinones having a bicylcic/3.1.0/ hexane containing group as antibiotic |
| 07/03/2003 | US20030125366 Phorboxazole derivatives for treating cancer |
| 07/03/2003 | US20030125363 Riluzole and alpha-tocopherol combination |
| 07/03/2003 | US20030125362 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 07/03/2003 | US20030125361 1H-benzo(g)indazole compounds as anticarcinogenic agents and also treat arthritis |
| 07/03/2003 | US20030125360 Carbocyclic hydrazino inhibitors of copper-containing amine oxidases |
| 07/03/2003 | US20030125359 RAF-MEK-ERK pathway inhibitors to treat cancer |
| 07/03/2003 | US20030125358 Pharmaceutical compositions containing thiazolidinedione derivatives and process for their preparation |
| 07/03/2003 | US20030125357 Therapeutic compounds for treating dyslipidemic conditions |
| 07/03/2003 | US20030125356 Reacting a methylketophenolic compound with a benzaldehyde compound to produce an intermediate, cyclizing the intermediate in presence of a base; anticarcinogenic agent, and treats diseases induced by cell proliferation |
| 07/03/2003 | US20030125354 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases |
| 07/03/2003 | US20030125353 Method of treatment |
| 07/03/2003 | US20030125352 8-azabicyclo (3.2.1)octane derivatives useful for treatment of neurodegenerative or psychological disorders |
| 07/03/2003 | US20030125351 Administering a heterocyclic amide compound to a glaucoma patient for inhibiting contraction of ciliary muscle; Rho kinase inhibitor |
| 07/03/2003 | US20030125350 Combination of formoterol and a tiotropium salt |
| 07/03/2003 | US20030125349 Medicament containing cilansetron for the treatment of non-obstipative male irritable bowel syndrome patients |
| 07/03/2003 | US20030125348 Minocycline compound substitued at 9-position by a group selected from nitro, alkyl, alkenyl, alkynyl, aryl, alkoxy, alkylthio, alkylsufinyl, alkylsulfonyl, amino, thionitroso, arylalkynyl or carbamate, urea, and sulfonamide |
| 07/03/2003 | US20030125347 An oral dosage form containing an opiate and a capsaicinoid irritant, opiate is selected from codeine, hydrocodone, hydromorphone, levorphanol, meperidine, morphine, oxycodone and their salts for the traeatment of drug abuse |
| 07/03/2003 | US20030125346 Amino-substituted pyrimidinyl derivatives and methods of use |
| 07/03/2003 | US20030125345 Nicotinic compounds; treating central nervous system disorders |
| 07/03/2003 | US20030125344 Rho-kinase inhibitors |
| 07/03/2003 | US20030125343 Combinations of receptor tyrosine kinase inhibitor with an a1-acidic glycoprotein binding compound |
| 07/03/2003 | US20030125342 6-substituted biaryl purine derivatives as potent cyclin/CDK inhibitors and antiproliferative agents |
| 07/03/2003 | US20030125340 3-(Amino-or aminoalkyl) pyridinone derivatives and their use for the treatment of HIV related diseases |
| 07/03/2003 | US20030125339 Substituted alkylamine derivatives and methods of use |
| 07/03/2003 | US20030125338 Compounds, compositions and methods for modulating beta-amyloid production |
| 07/03/2003 | US20030125337 Enhancing the antibacterial action of fluoroquinolones by contacting a bacterium with an indole, a urea, an aromatic amide or a quinoline |
| 07/03/2003 | US20030125335 Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia |
| 07/03/2003 | US20030125334 5-HT receptor ligands and uses thereof |
| 07/03/2003 | US20030125333 Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition |
| 07/03/2003 | US20030125332 Pyrazolo(3,4-c)pyridazin-3-ylamine derivatives; glycogen synthase kinase-3 (gsk-3); treatment and prevention of diabetes and Alzheimer's disease |
| 07/03/2003 | US20030125331 Treating drug-resistant HIV |